NewAmsterdam Pharma Company N.V.NAMS
Close of Friday, October 23, 2026 · NewAmsterdam Pharma Company N.V. is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$19.71
vs its Pivot
-34.6%
OnlyAlpha Score
32
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -13.3% | -43.8% | -43.7% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IBB · 0.13%
Big investors that own it (latest 13F)
| RA Capital | 2.8% of holdings |
| Duquesne Family Office | 2.4% of holdings |
| Viking Global | 0.4% of holdings |
Get NAMS in your free daily emailAfter every close: whether NAMS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track NAMS free → Full Stock check
Track NAMS free → Full Stock check